Genfit (GNFT) News Today €3.13 -0.17 (-5.04%) As of 09/23/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock GNFT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Genfit shares drop after halting VS-01 liver failure trialSeptember 22 at 8:48 AM | msn.comGENFIT S.A.: June 17, 2025 Combined Shareholders Meeting ResultsJune 18, 2025 | finanznachrichten.deGENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in ItalyMay 21, 2025 | morningstar.comMEuropean Equities Traded in the US as American Depositary Receipts Sharply Higher in Wednesday TradingApril 23, 2025 | msn.comGuggenheim Reaffirms Their Buy Rating on Genfit (GNFTF)March 31, 2025 | markets.businessinsider.comGENFIT S.A.: GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holdersMarch 21, 2025 | finanznachrichten.deEuropean Equities Traded in the US as American Depositary Receipts Surge Higher in Monday TradingMarch 3, 2025 | msn.comGenfit reports preliminary results of repurchase offer to 2025 OCEANEs holdersFebruary 21, 2025 | msn.comGENFIT S.A.: GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs HoldersFebruary 10, 2025 | finanznachrichten.deGenfit announces final terms for dual proposal to 2025 Oceanes holdersFebruary 10, 2025 | markets.businessinsider.comGENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs HoldersFebruary 10, 2025 | markets.businessinsider.comGENFIT S.A.: GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025February 7, 2025 | finanznachrichten.deEsker And Two High Growth Tech Stocks In FranceSeptember 24, 2024 | finance.yahoo.comBuy Rating Affirmed for Genfit SA on Financial Milestones and Promising Drug ApprovalsSeptember 20, 2024 | markets.businessinsider.comGENFIT S.A.: GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateSeptember 20, 2024 | finanznachrichten.deGENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateSeptember 19, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday TradingSeptember 11, 2024 | msn.comInnate Pharma (IPH)September 1, 2024 | investing.comGilead wins FDA nod for liver disease drugAugust 15, 2024 | msn.comPositive Outlook for Genfit SA with EU Approval Anticipated and Promising Pipeline DevelopmentsJuly 29, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%April 26, 2024 | msn.comBuy Rating Reiterated for Genfit SA Amidst Promising Clinical Developments and Strong Financial OutlookApril 8, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week LowerApril 5, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Laboratory (LH)April 5, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday TradingFebruary 15, 2024 | msn.comGenfit (GNFTF) Gets a Buy from Kepler CapitalFebruary 13, 2024 | markets.businessinsider.comGenfit S.A. (GNFT.PA)January 20, 2024 | finance.yahoo.comGENFIT Announces 2024 Financial CalendarJanuary 15, 2024 | finance.yahoo.comBuy Rating Affirmed for Genfit SA Amid Favorable Regulatory Developments and Positive Trial ResultsDecember 11, 2023 | markets.businessinsider.comGENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical TrialsDecember 6, 2023 | finance.yahoo.comGENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023November 16, 2023 | finance.yahoo.comGenfit stock rallies 20% after hours on data for liver disease drugNovember 13, 2023 | msn.comKepler Capital Sticks to Its Buy Rating for Genfit (GNFTF)November 12, 2023 | markets.businessinsider.comGENFIT S.A.: GENFIT Reports Third Quarter 2023 Financial InformationNovember 10, 2023 | finanznachrichten.deGENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023November 2, 2023 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Wednesday TradingNovember 1, 2023 | msn.comUBS starts Cymabay at buy, expecting positive Phase 3 data for seladelparAugust 14, 2023 | msn.comGENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology CommunicationsAugust 11, 2023 | finance.yahoo.comAnalyst Expectations for Genfit's FutureJuly 3, 2023 | markets.businessinsider.comGenfit gains as Phase 3 trial for liver disease candidate succeeds (update)June 30, 2023 | msn.comIpsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBCJune 30, 2023 | markets.businessinsider.comGenfit (EPA:GNFT) Price Target Decreased by 11.94% to 8.02June 4, 2023 | msn.comGENFIT: May 24, 2023 Combined Shareholders Meeting resultsMay 24, 2023 | finance.yahoo.comGENFIT S.A.: GENFIT Reports First Quarter 2023 Financial InformationMay 12, 2023 | finanznachrichten.deGenfit: Major Data Release Before End Of Q2 Of 2023 Could Get Ball RollingMay 11, 2023 | msn.comGENFIT Reports First Quarter 2023 Financial InformationMay 11, 2023 | finance.yahoo.comGENFIT Announces Publication of Extra-Financial Performance Report 2022April 27, 2023 | finance.yahoo.comEuropean Equities Move Modestly Higher in Friday Trading, But Set to End Week LowerApril 21, 2023 | msn.comEuropean Equities Nudge Higher in Tuesday Trading on Rising Bank, Pharma StocksApril 18, 2023 | msn.comGENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-FApril 18, 2023 | finance.yahoo.com Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNFT Media Mentions By Week GNFT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼-0.990.71▲Average Medical News Sentiment GNFT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼10▲GNFT Articles Average Week Get the Latest News and Ratings for GNFT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genfit and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Merck KGaA News ad pepper media International News Biotest Aktiengesellschaft News Medigene News Fielmann Group News Fresenius SE & Co. KGaA News Sanofi News Sartorius Stedim Biotech News Siemens Healthineers News Bayer Aktiengesellschaft News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:GNFT) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genfit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNFT Stock Alerts